In Two Fast-Track SWIFT Cases, One Voluntary Discontinuance of Claims, and One National Advertising Division Recommendation to Discontinue Claims

The National Advertising Division (NAD) of BBB National Programs closed two new Fast-Track SWIFT cases in June:

  • Function challenged PerSe Beauty’s “over 192,000 5-star product reviews” claim.
  • Nestle Nutrition challenged Reckitt Benckiser’s exclusivity claims about the ingredients of the Enfamil brand’s Nutramigen line of infant formula products.

Fast-Track SWIFT is an expedited NAD process designed for single-issue advertising cases.

Function Inc. v. PerSé Beauty Inc. d/b/a Prose
Function brought a challenge to Prose’s claim that it had “over 192,000 5-star product reviews!” for its customizable hair care products. NAD recommended that the advertiser discontinue the challenged claim.

The “over 192,000 5-star product reviews” claim was appropriate for Fast-Track SWIFT because the issue was limited to the presentation of the advertiser’s product reviews, including whether the advertiser provided a reasonable basis for the claim.

Marketing Technology News: Cogniac Joins NVIDIA Inception Program

The advertiser formulates a customer’s product from the result of their online hair and lifestyle survey and continuously tailors the formula based on the customer’s post-purchase feedback, a process it refers to as its “Review & Refine” experience. As part of its process, Prose solicits star-ratings on aspects of the customer’s experience after each purchase — overall experience, satisfaction per product, and various product attributes. It may revise its formulation after each purchase. For example, if the customer indicated that they would prefer a stronger fragrance – that adjustment is made on subsequent purchases. The iterative process of reviewing and refining happens every time the customer orders. NAD noted that nothing in the context of the challenged unqualified “192,000” claim, or the claim itself, alerts consumers that its count of 5-star reviews is based on Prose’s “Review and Refine” experience.

Reasonable consumers may not expect that the number of reviews is the result of a back-and-forth process of altering and re-reviewing the product to increase consumer satisfaction. NAD determined that the “Review and Refine” process provides a meaningful consumer benefit, but any claim based on aggregated product reviews should indicate the way in which this level of customer satisfaction is achieved to avoid conveying a misleading message.

In its advertiser’s statement, Prose stated that while it “respectfully disagrees with NAD’s assessment of Prose’s claim regarding the number of 5-star product reviews it has received, we appreciate NAD’s guidance.”

Nestle Nutrition v. Mead Johnson Nutrition of Reckitt Benckiser
Nestle Nutrition challenged claims that appeared in online advertising for Nutramigen infant formula. The challenged claims included:

  • Nutramigen is “the only hypoallergenic formula with no sugar (sucrose) added.”
  • Nutramigen is “the only hypoallergenic formula with probiotics to support immune system and digestive health.”
  • Nutramigen is “the only hypoallergenic brand with expert recommended DHA amount.”

In response to Nestle Nutrition’s SWIFT challenge, the advertiser stated that for business purposes it agreed to permanently discontinue the challenged claims. NAD noted that because permanent discontinuance of the claims had not been fully completed prior to the challenge, it did not administratively close the case but instead maintained jurisdiction so that it may review the matter for compliance.

Although mooted by the advertiser’s permanent discontinuance of the challenged claims, NAD nevertheless found that the challenge was appropriate for Fast-Track SWIFT because the issue of whether the advertiser’s exclusivity claims about Nutramigen’s ingredients was supported was not likely to require the review of complex evidence.

Marketing Technology News: Bubblr Provides Key Patent Update

Brought to you by
For Sales, write to: contact@martechseries.com
Copyright © 2024 MarTech Series. All Rights Reserved.Privacy Policy
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.